HOME >> BIOLOGY >> NEWS
NIH selects Purdue to use phi29 DNA packaging motor for National Nanomedicine Development Center

WEST LAFAYETTE, Ind. -- A multidisciplinary Purdue research team will lead one of eight national nanomedicine development centers.

The National Institutes of Health awarded the team $7 million over five years to study the use of a nanomotor, a microscopic biological machine, for potential use in the diagnosis and treatment of diseases such as cancer, AIDS, hepatitis B and influenza.

The team will take the first steps in research that could lead to using nanomotors to package and deliver therapeutic DNA or RNA to disease-causing cells. This is a feat that could revolutionize medicine, but it faces many challenges, said Peixuan Guo, director of the center and a professor of molecular virology with joint appointments in Purdue's Cancer Research Center, School of Veterinary Medicine and Weldon School of Biomedical Engineering.

"Nanomedicine, a branch of nanotechnology, calls upon many fields, including engineering, biology, chemistry, mathematics, computation and physics," Guo said. "The NIH centers bring these scientists together and that is the most exciting aspect of this project. We hope to create a medical tool using a device that mimics a natural biological structure. This biomimetic tool will be a hybrid of natural biological structures and synthetic structures that will operate on the nanoscale."

Nanotechnology is defined as structures, devices and systems 1 to 100 nanometers in size that possess novel properties and functions due to the arrangement of their atoms and molecules. A nanometer is one-billionth of a meter, or 100,000 times smaller than the diameter of a human hair.

The NIH nanomedicine initiative is a network of centers studying biological systems at the nanoscale in an effort to understand and control the molecular complexes responsible for cellular processes. The long-term goal is to develop devices that can control these processes for diagnosis and treatment of diseases. Four nanomedicine cente
'"/>

Contact: Elizabeth K. Gardner
ekgardner@purdue.edu
765-494-2081
Purdue University
4-Dec-2006


Page: 1 2 3 4 5

Related biology news :

1. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
2. EPA selects Phylonix to screen compound library in zebrafish
3. OneWorld Health selects Odyssey Research for phase 4 study in India
4. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
5. IUBMB selects Wiley to publish Biochemistry and Molecular Biology Education
6. NIH selects Pittsburgh institute as leader for HIV/AIDS prevention efforts
7. EMBO selects Europes best young independent scientists
8. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
9. NHGRI selects 13 new targets for large-scale sequencing program
10. Purdue-IU researchers explore new method for early disease diagnosis
11. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC ... services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ... patients with severe COVID-19. This is the first study of an XPO1 inhibitor ...
(Date:6/23/2020)... , ... June 22, 2020 , ... The field of ... ligand binding assays (LBA) have dominated this area. However, the use of mass spectrometry ... , This now necessitates the question “How do you choose which approach to use ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell biotechnology ... the stem cell medicine and pharmaceutical industries have easier access to stem cell counting, ... July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is offering ...
Breaking Biology News(10 mins):
(Date:6/19/2020)... PETERSBURG, Russia (PRWEB) , ... June 18, 2020 , ... ... in 2018. Its goal is to join forces to radically prolong life and find ... significantly postpone the aging period. This project was supported by various scientists from all ...
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has been and will continue ... to stock market dips, ways to reduce CO2 is something we can’t avoid. ... of the biofuels being produced today are created from recycled cooking oil or crops. ...
(Date:5/30/2020)... ... May 29, 2020 , ... The Conference Forum is pleased ... dedicated to the unique role of the Chief Medical Officer in the biotech ... problem-solving, best practices and career development of CMOs and Heads of R&D from ...
(Date:5/21/2020)... ... 2020 , ... Threats to intellectual property, political pressure to ... conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a ... pandemic commercially weaker, dealing with delays in new product launches and with fewer ...
Breaking Biology Technology:
Cached News: